Early Access — free while we kick the tires
EdgarHawk

AEI Capital Ltd

10% Owner

10% Owner
3 filings analyzed · 1 company · Latest 2025-07-30

Companies

Company Buys Sells Direction
OPGEN INC OPGN 9 0 Net buying

Activity

July 2025
2025-07-30 OPGEN INC OPGN
medium
Buy
1,000 shares
$4,790
Significance 2/10

10% Owner AEI Capital Ltd purchases 1,000 OPGN shares at $4.79; adds to 7.65M position amid 5 prior OPGN buys all showing -100% 90d returns.

AEI Capital Ltd, a 10% shareholder, purchased 1,000 shares of OPGEN at $4.79 on 2025-07-30, increasing holdings from 7,645,603 to 7,646,603 shares. The current price of $4.70 is -9.3% from the 52-week high and -3.7% over 30 days. However, this buy follows a deeply concerning pattern: all 5 of AEI's prior purchases at OPGN (between August 8–29, 2024) each resulted in -100% 90-day returns, with 0 of 5 buys showing positive post-purchase performance. Across AEI's broader open-market history, 6 prior buys averaged -100.0% 90-day return with a 0.00% win rate. The lack of success in timing previous OPGN purchases raises material questions about whether continued accumulation at these price levels represents informed capital allocation or a pattern of purchasing into declining positions.

December 2024
2024-12-10 OPGEN INC OPGN
critical
Buy
2,400,000 shares
$1,916,326,200,000
Significance 9/10

AEI Capital (10% owner) purchases 2,400,000 shares in 2 transactions for $1,916.3B; stock has collapsed -83.3% from 52-week high and trades at $1.30 vs. blended buy price of $798,469.25

AEI Capital executed 2 separate purchases totaling 2,400,000 shares for $1,916,326,200,000.00 on 2024-08-05 and 2024-08-08 at a blended average price of $798,469.25. The current market price of $1.30 stands -83.3% below the 52-week high and represents a devastating drawdown relative to the transaction prices paid. AEI Capital's cross-ticker track record shows 4 prior buys with an average 90-day return of -100.0% and a 0.00% win rate, while its 5 prior trades at OPGN have uniformly underperformed post-purchase: all 4 prior buys at this ticker show -100.0% returns at the 90-day mark, with only 1 of 5 prior trades well-timed overall. OPGN's fundamentals are severely distressed—the company was unprofitable over its most recent full fiscal year, generated only $28,000 in latest quarterly revenue against a $13.1M market cap, and the stock has declined -35.6% over 90 days and -23.5% over 30 days, creating a pattern where AEI Capital's timing and selection judgment at this ticker has been persistently poor.

October 2024
2024-10-08 OPGEN INC OPGN
critical
Buy
5,245,603 shares
$11,130,140,980,409
Significance 9/10

10% owner AEI Capital acquired 5.25M shares ($11.1B invested) vs sold 2.40M ($1.9B) in Aug 2024; stock now down 83.6% from 52-week high to $1.95.

AEI Capital, a 10% shareholder, executed 4 separate purchases totaling 5,245,603 shares for $11,130,140,980,409.00 across August 2024, while simultaneously divesting 2,400,000 shares for $1,916,326,200,000.00 in net accumulation of 2,845,603 shares (+59.3% increase in holdings). The per-share prices in the purchases (ranging from $428,724 on 2024-08-13 to $2,724,490 on 2024-08-16) were dramatically higher than the current market price of $1.95, which stands 83.6% below the 52-week high of $11.90. OPGN is currently unprofitable with negative net income of $-1,576,349.00 in the latest quarter and a market cap of only $16,293,217.20, indicating severe fundamental distress. The insider's prior trades at this ticker show a pattern of immediate underwater positions (30d return of -100.0% on both the 2024-08-05 and 2024-08-08 buys), and the cross-ticker track record shows the same pattern (2 prior buys with average 30d return of -100.0%). This filing documents a substantial capital deployment into a deeply distressed, unprofitable microcap that has since collapsed in valuation, raising questions about execution risk, purchase timing, and the underlying strategic rationale for such aggressive accumulation.

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access